skip to main content
European Commission Logo
en English
Newsroom

Understanding cancer progression to improve treatment

As Europe's population ages, cancer has become the leading cause of death. Therapeutic targeting - changing the activity of a protein or nucleic acid with a stimulus - is of limited use because of the complexity of cancer: changes take place within the tumour cell itself, but also in the cell's microenvironment. An EU-funded project will increase understanding of cancer progression and provide the basis for new, targeted approaches.

Image of syringe and molecules
cutimage - fotolia.com

date:  19/01/2017

Project:  Matrix glycans as multifunctional pathog...

acronym:  GLYCANC

See alsoProject details

Many events can allow cancer cells to survive – tumour-stroma interactions and contact with immune cells. This can lead to metastasis, which is the leading cause of cancer-associated mortality.

Read more